Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · February 07, 2021

Similarly Low Risk of HCC After Spontaneous or Nucleos(t)ide Analogue–Induced HBsAg Loss

Alimentary Pharmacology & Therapeutics


Additional Info

Alimentary Pharmacology & Therapeutics
Similarly Low Risk of Hepatocellular Carcinoma After Either Spontaneous or Nucleos(t)ide Analogue–Induced Hepatitis B Surface Antigen Loss
Aliment. Pharmacol. Ther. 2021 Jan 01;53(2)321-331, TC Yip, VW Wong, YK Tse, LY Liang, VW Hui, X Zhang, GL Li, GC Lui, HL Chan, GL Wong

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading